Lion Licenses SRS to Johnson & Johnson PRD | GenomeWeb

NEW YORK, Jan. 22-Lion Bioscience has licensed its SRS bioinformatics platform to Johnson & Johnson Pharmaceutical Research and Development for two years, the company said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.